Clinical trial
A Prospective, Multicenter Observational Study of Efficacy and Safety of Polymer-free Amphilimus-eluting Stent (Cre8™/Cre8™ EVO) in Patients With Coronary Artery Disease According to the Presence of Diabetes Mellitus
NCT05759676 is registered in ClinicalTrials.gov with Korea University Anam Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter Observational Study of Efficacy and Safety of Polymer-free Amphilimus-eluting Stent (Cre8™/Cre8™ EVO) in Patients With Coronary Artery Disease According to the Presence of Diabetes Mellitus
- Lead sponsor
- Korea University Anam Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- March 9, 2023
- Completion date
- December 31, 2026
- Enrollment
- 1,800 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.